Pfizer Inc. (PFE.F)
EUR 25.0
(-0.48%)
EUR 25.0
(-0.48%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 58.49 Billion | 100.33 Billion | 81.28 Billion | 41.9 Billion | 51.75 Billion | 53.64 Billion |
| Cost of Revenue | 24.95 Billion | 34.34 Billion | 30.82 Billion | 8.69 Billion | 10.21 Billion | 11.24 Billion |
| Gross Profit | 33.54 Billion | 65.98 Billion | 50.46 Billion | 33.21 Billion | 41.53 Billion | 42.39 Billion |
| Operating Expenses | 30.18 Billion | 28.71 Billion | 30.23 Billion | 24.45 Billion | 27.61 Billion | 27.35 Billion |
| Selling, General and Administrative Expenses | 14.77 Billion | 13.67 Billion | 12.7 Billion | 11.61 Billion | 14.35 Billion | 14.45 Billion |
| Research and Development Expenses | 10.67 Billion | 11.42 Billion | 13.82 Billion | 9.4 Billion | 8.65 Billion | 8 Billion |
| Other Expenses | 4.73 Billion | 2.07 Billion | 4.09 Billion | 1.49 Billion | 972 Million | 1.14 Billion |
| Cost and Expenses | 55.13 Billion | 63.05 Billion | 61.05 Billion | 33.14 Billion | 37.82 Billion | 38.6 Billion |
| Operating Income | 3.35 Billion | 40.03 Billion | 24.83 Billion | 10.63 Billion | 15.13 Billion | 16.51 Billion |
| Interest Expense | 2.2 Billion | 1.23 Billion | 1.29 Billion | 1.44 Billion | 1.57 Billion | 1.31 Billion |
| Income Tax Expense | -1.11 Billion | 3.32 Billion | 1.85 Billion | 477 Million | 1.38 Billion | 706 Million |
| Earnings before Tax | 1.05 Billion | 34.72 Billion | 24.31 Billion | 7.49 Billion | 17.68 Billion | 11.88 Billion |
| Net Income | 2.11 Billion | 31.37 Billion | 21.97 Billion | 9.15 Billion | 16.02 Billion | 11.15 Billion |
| Earnings Per Share Basic | 0.37 | 5.59 | 3.92 | 1.65 | 2.92 | 1.90 |
| Earnings Per Share Diluted | 0.37 | 5.47 | 3.85 | 1.63 | 2.87 | 1.87 |
| Weighted Average Shares Outstanding | 5.72 Billion | 5.6 Billion | 5.6 Billion | 5.55 Billion | 5.56 Billion | 5.87 Billion |
| Weighted Average Shares Outstanding (Diluted) | 5.7 Billion | 5.73 Billion | 5.7 Billion | 5.63 Billion | 5.67 Billion | 5.97 Billion |
| Gross Margin | 0.57 | 0.66 | 0.62 | 0.79 | 0.80 | 0.79 |
| EBIT Margin | 0.16 | 0.43 | 0.35 | 0.34 | 0.38 | 0.40 |
| Profit Margin | 0.04 | 0.31 | 0.27 | 0.22 | 0.31 | 0.21 |
| EBITDA | 9.55 Billion | 43.63 Billion | 30.79 Billion | 13.26 Billion | 18.64 Billion | 11.06 Billion |
| Earnings Before Tax Margin | 0.06 | 0.40 | 0.31 | 0.25 | 0.29 | 0.31 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 13.28 Billion | 14.87 Billion | 58.49 Billion | 14.24 Billion | 13.23 Billion | 12.73 Billion |
| Cost of Revenue | 3.3 Billion | 3.37 Billion | 24.95 Billion | 7.56 Billion | 9.26 Billion | 3.23 Billion |
| Gross Profit | 9.98 Billion | 11.49 Billion | 33.54 Billion | 6.68 Billion | 3.96 Billion | 9.49 Billion |
| Operating Expenses | 7.72 Billion | 7.29 Billion | 30.18 Billion | 8.65 Billion | 7.17 Billion | 7.32 Billion |
| Selling, General and Administrative Expenses | 3.71 Billion | 3.49 Billion | - | 4.57 Billion | 3.28 Billion | 3.49 Billion |
| Research and Development Expenses | 2.69 Billion | 2.49 Billion | - | 2.81 Billion | 2.71 Billion | 2.64 Billion |
| Other Expenses | 230 Million | 361 Million | 2.67 Billion | 1.03 Billion | 574 Million | 385 Million |
| Cost and Expenses | 11.02 Billion | 10.67 Billion | 55.13 Billion | 16.22 Billion | 16.44 Billion | 10.56 Billion |
| Operating Income | 2.97 Billion | 4.6 Billion | 8.15 Billion | -183 Million | -1.98 Billion | 3.02 Billion |
| Interest Expense | 778 Million | 790 Million | 2.2 Billion | 688 Million | 695 Million | 508 Million |
| Income Tax Expense | -134 Million | 293 Million | -1.11 Billion | -795 Million | -964 Million | -71 Million |
| Earnings before Tax | -103 Million | 3.42 Billion | 1.05 Billion | -4.12 Billion | -3.35 Billion | 2.26 Billion |
| Net Income | 41 Million | 3.11 Billion | 2.11 Billion | -3.36 Billion | -2.38 Billion | 2.32 Billion |
| Earnings Per Share Basic | 0.00 | 0.55 | - | -0.60 | -0.42 | 0.41 |
| Earnings Per Share Diluted | 0.00 | 0.55 | - | -0.60 | -0.42 | 0.41 |
| Weighted Average Shares Outstanding | 5.66 Billion | 5.65 Billion | 5.64 Billion | 5.64 Billion | 5.64 Billion | 5.64 Billion |
| Weighted Average Shares Outstanding (Diluted) | 5.69 Billion | 5.69 Billion | 5.64 Billion | 5.64 Billion | 5.64 Billion | 5.71 Billion |
| Gross Margin | 0.75 | 0.77 | 0.57 | 0.47 | 0.30 | 0.75 |
| EBIT Margin | 0.33 | 0.43 | - | 0.10 | -0.06 | 0.33 |
| Profit Margin | 0.00 | 0.21 | 0.04 | -0.24 | -0.18 | 0.18 |
| EBITDA | 4.39 Billion | 6.34 Billion | - | 1.48 Billion | -803 Million | 4.21 Billion |
| Earnings Before Tax Margin | 0.22 | 0.31 | 0.14 | -0.01 | -0.15 | 0.24 |
HLM
ERWE
FTEG
NNFSF
1213
WRDEF